A snapshot of pediatric inpatients and outpatients with COVID-19: a point prevalence study from Turkey

dc.contributor.authorYilmaz, D
dc.contributor.authorÜstündag, G
dc.contributor.authorBüyükçam, A
dc.contributor.authorSali, E
dc.contributor.authorÇelik, Ü
dc.contributor.authorAvcu, G
dc.contributor.authorBelet, N
dc.contributor.authorTaskin, EÇ
dc.contributor.authorDemir, SÖ
dc.contributor.authorBirbilen, AZ
dc.contributor.authorKiliç, Ö
dc.contributor.authorAkcan, ÖM
dc.contributor.authorYilmaz, AT
dc.contributor.authorKocabas, BA
dc.contributor.authorHatipoglu, N
dc.contributor.authorKarbuz, A
dc.contributor.authorÇakir, D
dc.contributor.authorSütçü, M
dc.contributor.authorAygün, FD
dc.contributor.authorÇelik, T
dc.contributor.authorSen, SB
dc.contributor.authorDalgiç, N
dc.contributor.authorÜmit, Z
dc.contributor.authorKara, SS
dc.contributor.authorÖncel, EK
dc.contributor.authorBolat, A
dc.contributor.authorÇil, MK
dc.contributor.authorTuran, C
dc.contributor.authorGuzin, AÇ
dc.contributor.authorTopal, S
dc.contributor.authorBesli, GE
dc.contributor.authorDogan, G
dc.contributor.authorSahin, S
dc.contributor.authorAkin, F
dc.contributor.authorBildirici, Y
dc.contributor.authorDayar, GT
dc.contributor.authorSari, EE
dc.contributor.authorIsançli, DK
dc.contributor.authorKara, M
dc.contributor.authorÖnal, P
dc.contributor.authorAylaç, H
dc.contributor.authorLüleci, D
dc.contributor.authorYasar, B
dc.contributor.authorDede, E
dc.contributor.authorÇaglar, A
dc.contributor.authorAkova, S
dc.contributor.authorTurgut, EA
dc.contributor.authorÖzkaya, PY
dc.contributor.authorGülmez, TK
dc.contributor.authorUlusoy, E
dc.contributor.authorDuyu, M
dc.contributor.authorKara, Y
dc.contributor.authorÇeliktas, H
dc.contributor.authorTekeli, O
dc.contributor.authorÇaglar, F
dc.contributor.authorGül, D
dc.contributor.authorCebeci, SO
dc.contributor.authorBattal, F
dc.contributor.authorBal, A
dc.contributor.authorAygün, E
dc.contributor.authorUysalol, M
dc.contributor.authorArslan, G
dc.contributor.authorÖzkavakli, A
dc.contributor.authorKizil, MC
dc.contributor.authorYazar, A
dc.contributor.authorAygün, F
dc.contributor.authorSomer, A
dc.contributor.authorKuyucu, N
dc.contributor.authorDinleyici, EÇ
dc.contributor.authorKara, A
dc.date.accessioned2024-07-18T12:08:23Z
dc.date.available2024-07-18T12:08:23Z
dc.description.abstractThis multi-center point prevalence study evaluated children who were diagnosed as having coronavirus disease 2019 (COVID19). On February 2nd, 2022, inpatients and outpatients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were included in the study from 12 cities and 24 centers in Turkey. Of 8605 patients on February 2nd, 2022, in participating centers, 706 (8.2%) had COVID-19. The median age of the 706 patients was 92.50 months, 53.4% were female, and 76.7% were inpatients. The three most common symptoms of the patients with COVID-19 were fever (56.6%), cough (41.3%), and fatigue (27.5%). The three most common underlying chronic diseases (UCDs) were asthma (3.4%), neurologic disorders (3.3%), and obesity (2.6%). The SARS-CoV-2-related pneumoniae rate was 10.7%. The COVID-19 vaccination rate was 12.5% in all patients. Among patients aged over 12 years with access to the vaccine given by the Republic of Turkey Ministry of Health, the vaccination rate was 38.7%. Patients with UCDs presented with dyspnea and pneumoniae more frequently than those without UCDs (p < 0.001 for both). The rates of fever, diarrhea, and pneumoniae were higher in patients without COVID-19 vaccinations (p = 0.001, p = 0.012, and p = 0.027). Conclusion: To lessen the effects of the disease, all eligible children should receive the COVID-19 vaccine. The illness may specifically endanger children with UCDs.
dc.identifier.issn0340-6199
dc.identifier.other1432-1076
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/10929
dc.language.isoEnglish
dc.publisherSPRINGER
dc.subjectHOSPITALIZED-PATIENTS
dc.subjectCHILDREN
dc.subjectDISEASE
dc.titleA snapshot of pediatric inpatients and outpatients with COVID-19: a point prevalence study from Turkey
dc.typeArticle

Files